News
-
-
COMMUNIQUÉ DE PRESSE
Befesa delivers resilient H1 2025 performance, net profit doubles to €40m, adjusted EBITDA up 9% to €112m and sees stronger H2
Befesa delivers resilient H1 2025 performance with net profit doubling to €40m and adjusted EBITDA up 9% to €112m. Stronger H2 anticipated amid operational resilience and growth initiatives -
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site
Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside -
-
-